Zebularine-induced reduction in VEGF secretion by HIF-1α degradation in oral squamous cell carcinoma

Maiko Suzuki, Fumiaki Shinohara, Hidemi Rikiishi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Vascular endothelial growth factor (VEGF) is a potent inducer of angiogenesis in oral squamous cell carcinoma (OSCC). In this study, we used the novel DNA methyltransferase inhibitor zebularine (Zeb) to investigate epigenetic influences on the secretion of VEGF-A in the OSCC cell line HSC-3. Under normoxic conditions, we found that Zeb inhibited secretion in a dose-dependent manner by reducing the activity of hypoxia-inducible factor-1α (HIF-1α). Treatment of the cells with the proteasome inhibitor MG132 protected the HIF-1α protein from Zeb-mediated epigenetic regulation. In addition, our study revealed that neither the PI3K/Akt nor the p53 signaling pathway is required for Zeb-induced HIF-1α degradation. In short, Zeb influenced the stability of the HIF-1α protein and the activity of its targets, such as VEGF, in HSC-3 cells in normoxic conditions. This study has laid the foundation for a novel anti-cancer approach, which may find applications in molecular staging.

Original languageEnglish (US)
Pages (from-to)465-471
Number of pages7
JournalMolecular Medicine Reports
Volume1
Issue number4
StatePublished - Dec 1 2008
Externally publishedYes

Fingerprint

pyrimidin-2-one beta-ribofuranoside
Hypoxia-Inducible Factor 1
Vascular Endothelial Growth Factor A
Squamous Cell Carcinoma
Degradation
Epigenomics
Cells
Proteasome Inhibitors
Angiogenesis Inducing Agents
Methyltransferases
Phosphatidylinositol 3-Kinases
Proteins
Epithelial Cells
Cell Line

Keywords

  • Epigenetics
  • Hypoxia-inducible factor-1α
  • Oral squamous cell carcinoma
  • Vascular endothelial growth factor
  • Zebularine

ASJC Scopus subject areas

  • Biochemistry
  • Cancer Research
  • Genetics
  • Molecular Biology
  • Molecular Medicine
  • Oncology

Cite this

Zebularine-induced reduction in VEGF secretion by HIF-1α degradation in oral squamous cell carcinoma. / Suzuki, Maiko; Shinohara, Fumiaki; Rikiishi, Hidemi.

In: Molecular Medicine Reports, Vol. 1, No. 4, 01.12.2008, p. 465-471.

Research output: Contribution to journalArticle

@article{e39354a57e7843939b42605c3ca37ba3,
title = "Zebularine-induced reduction in VEGF secretion by HIF-1α degradation in oral squamous cell carcinoma",
abstract = "Vascular endothelial growth factor (VEGF) is a potent inducer of angiogenesis in oral squamous cell carcinoma (OSCC). In this study, we used the novel DNA methyltransferase inhibitor zebularine (Zeb) to investigate epigenetic influences on the secretion of VEGF-A in the OSCC cell line HSC-3. Under normoxic conditions, we found that Zeb inhibited secretion in a dose-dependent manner by reducing the activity of hypoxia-inducible factor-1α (HIF-1α). Treatment of the cells with the proteasome inhibitor MG132 protected the HIF-1α protein from Zeb-mediated epigenetic regulation. In addition, our study revealed that neither the PI3K/Akt nor the p53 signaling pathway is required for Zeb-induced HIF-1α degradation. In short, Zeb influenced the stability of the HIF-1α protein and the activity of its targets, such as VEGF, in HSC-3 cells in normoxic conditions. This study has laid the foundation for a novel anti-cancer approach, which may find applications in molecular staging.",
keywords = "Epigenetics, Hypoxia-inducible factor-1α, Oral squamous cell carcinoma, Vascular endothelial growth factor, Zebularine",
author = "Maiko Suzuki and Fumiaki Shinohara and Hidemi Rikiishi",
year = "2008",
month = "12",
day = "1",
language = "English (US)",
volume = "1",
pages = "465--471",
journal = "Molecular Medicine Reports",
issn = "1791-2997",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - Zebularine-induced reduction in VEGF secretion by HIF-1α degradation in oral squamous cell carcinoma

AU - Suzuki, Maiko

AU - Shinohara, Fumiaki

AU - Rikiishi, Hidemi

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Vascular endothelial growth factor (VEGF) is a potent inducer of angiogenesis in oral squamous cell carcinoma (OSCC). In this study, we used the novel DNA methyltransferase inhibitor zebularine (Zeb) to investigate epigenetic influences on the secretion of VEGF-A in the OSCC cell line HSC-3. Under normoxic conditions, we found that Zeb inhibited secretion in a dose-dependent manner by reducing the activity of hypoxia-inducible factor-1α (HIF-1α). Treatment of the cells with the proteasome inhibitor MG132 protected the HIF-1α protein from Zeb-mediated epigenetic regulation. In addition, our study revealed that neither the PI3K/Akt nor the p53 signaling pathway is required for Zeb-induced HIF-1α degradation. In short, Zeb influenced the stability of the HIF-1α protein and the activity of its targets, such as VEGF, in HSC-3 cells in normoxic conditions. This study has laid the foundation for a novel anti-cancer approach, which may find applications in molecular staging.

AB - Vascular endothelial growth factor (VEGF) is a potent inducer of angiogenesis in oral squamous cell carcinoma (OSCC). In this study, we used the novel DNA methyltransferase inhibitor zebularine (Zeb) to investigate epigenetic influences on the secretion of VEGF-A in the OSCC cell line HSC-3. Under normoxic conditions, we found that Zeb inhibited secretion in a dose-dependent manner by reducing the activity of hypoxia-inducible factor-1α (HIF-1α). Treatment of the cells with the proteasome inhibitor MG132 protected the HIF-1α protein from Zeb-mediated epigenetic regulation. In addition, our study revealed that neither the PI3K/Akt nor the p53 signaling pathway is required for Zeb-induced HIF-1α degradation. In short, Zeb influenced the stability of the HIF-1α protein and the activity of its targets, such as VEGF, in HSC-3 cells in normoxic conditions. This study has laid the foundation for a novel anti-cancer approach, which may find applications in molecular staging.

KW - Epigenetics

KW - Hypoxia-inducible factor-1α

KW - Oral squamous cell carcinoma

KW - Vascular endothelial growth factor

KW - Zebularine

UR - http://www.scopus.com/inward/record.url?scp=69249127912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249127912&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 465

EP - 471

JO - Molecular Medicine Reports

JF - Molecular Medicine Reports

SN - 1791-2997

IS - 4

ER -